Men could soon be offered quick MRI scans lasting under 15 minutes to detect prostate cancer earlier, under new recommendations from international experts.

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...

Former first lady Jill Biden has issued a rare health update on Joe Biden's battle with prostate cancer, saying that the former president is "doing well." ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.

Former President Biden's prostate cancer diagnosis was revealed in May 2025, four months after he left the White House having decided to drop out of the 2024 presidential race less than a year earlier ...